Passage Bio Inc. (PASG) Social Stream
PASSAGE BIO INC (PASG) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PASG.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-07 | 8 | $43 | $22 | $27.857 | $1.01 | 2658.12% |
| 2021-11-08 | 4 | $43 | $23 | $28.6 | $1.01 | 2731.68% |
| 2022-03-03 | 6 | $43 | $23 | $27.6 | $1.01 | 2632.67% |
| 2022-03-14 | 6 | $34 | $23 | $26.5 | $1.01 | 2523.76% |
| 2022-05-17 | 7 | $34 | $6 | $13.8 | $1.01 | 1266.34% |
| 2022-08-04 | 5 | $34 | $6 | $13.8 | $1.01 | 1266.34% |
| 2022-08-06 | 5 | $18 | $6 | $9.4 | $1.01 | 830.69% |
| 2022-11-08 | 6 | $18 | $6 | $9.166 | $1.01 | 807.52% |
| 2022-11-11 | 8 | $18 | $5 | $9 | $1.01 | 791.09% |
| 2023-01-17 | 8 | $11 | $5 | $8.333 | $1.01 | 725.05% |
| 2023-03-07 | 6 | $11 | $5 | $8.333 | $1.01 | 725.05% |
| 2023-05-11 | 7 | $11 | $5 | $8.333 | $1.01 | 725.05% |
| 2023-08-08 | 7 | $11 | $5 | $8.166 | $1.01 | 708.51% |
| 2023-10-24 | 6 | $9 | $4 | $7 | $1.01 | 593.07% |
| 2023-11-13 | 6 | $9 | $3 | $5.8 | $1.01 | 474.26% |
| 2023-11-14 | 6 | $8 | $3 | $5.4 | $1.01 | 434.65% |
The Trend in the Analyst Price Target
Over the past 21 months, PASG's average price target has gone down $22.1.
Over the past 43 weeks, PASG's average upside potential has been 724.5%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-07 | 7 | 11 | 5 | 8.333 | 1.260 | 561.35% |
| 2023-08-08 | 7 | 11 | 5 | 8.166 | 0.852 | 858.45% |
| 2023-10-24 | 6 | 9 | 4 | 7.000 | 0.657 | 965.45% |
| 2023-11-14 | 6 | 8 | 3 | 5.400 | 0.660 | 718.18% |
| 2023-11-14 | 5 | 8 | 3 | 5.500 | 0.660 | 733.33% |
PASG Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
PASG's average broker recommendation rating improved by 0.33 over the prior 20 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, PASSAGE BIO INC's upside potential (average analyst target price relative to current price) is greater than 3012.69% of them.
- In the context of all US stocks, PASSAGE BIO INC's variance in analysts' estimates is lower than -2493.23% of them.
- In terms of how PASSAGE BIO INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 2271.42% of that group.
- PASSAGE BIO INC's average analyst price target is greater than 808.32% of Healthcare stocks.
In the Pharmaceutical Products industry, BDTX, JSPR, and CABA are the three stocks most similar to PASSAGE BIO INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for PASG? Use POWR Ratings for clearer insight into price direction.